An exploratory, multi-center, open-label, single-arm study to evaluate the discontinuation effect of clopidogrel after drug eluting stent (DECADES) on inflammatory and platelet activation markers in subjects who are receiving low dose acetylsalicylic acid (ASA).
Phase of Trial: Phase IV
Latest Information Update: 19 Oct 2012
At a glance
- Drugs Clopidogrel (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Biomarker; Pharmacodynamics
- Acronyms DECADES
- Sponsors Bristol-Myers Squibb
- 01 Apr 2009 Sanofi-Aventis added as trial sponsor as reported by ClinicalTrials.gov.
- 14 Jul 2008 Actual patient number added (101) as reported by ClinicalTrials.gov.
- 14 Jul 2008 Actual end date added (Jun 2008) as reported by ClinicalTrials.gov.